TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

5 Stocks Under $10 Setting Up to Trade Higher
OPINION

5 Stocks Under $10 Setting Up to Trade Higher

  • By Roberto Pedone
  • Nov 22, 2015 4:05 PM EST
PRESS RELEASES

ContraFect Announces Funding Agreement With The Cystic Fibrosis Foundation

  • By GlobeNewswire
  • Aug 25, 2020 7:30 AM EDT
PRESS RELEASES

Contrafect Announces Publication Of Exebacase Phase 2 Study Results In The Journal Of Clinical Investigation

  • By GlobeNewswire
  • Jun 17, 2020 7:30 AM EDT
PRESS RELEASES

ContraFect Announces Appointment Of Lishan Aklog, M.D. To Board Of Directors

  • By GlobeNewswire
  • Jun 15, 2020 7:30 AM EDT
PRESS RELEASES

ContraFect Corporation Announces Private Placement Of Common Stock And Warrants To Pfizer Inc.

  • By GlobeNewswire
  • May 26, 2020 7:30 AM EDT
PRESS RELEASES

ContraFect Corporation Prices Approximately $52.5 Million Public Offering Of Common Stock And Warrants

  • By GlobeNewswire
  • May 21, 2020 10:59 PM EDT
PRESS RELEASES

ContraFect Corporation Announces Proposed Public Offering Of Common Stock And Warrants

  • By GlobeNewswire
  • May 21, 2020 4:09 PM EDT
PRESS RELEASES

ContraFect Announces Dr. Roger J. Pomerantz, Chief Executive Officer And Chairman, Invited As Keynote Speaker And Presenter In Maxim's Infectious Disease Virtual Conference

  • By GlobeNewswire
  • Apr 21, 2020 7:00 AM EDT
PRESS RELEASES

ContraFect To Chair And Participate In Virtual Superbugs & Superdrugs 2020 Conference

  • By GlobeNewswire
  • Mar 30, 2020 5:00 AM EDT
PRESS RELEASES

ContraFect To Present At FDA Workshop OnĀ Advancing Animal Models For Antibacterial Drug Development

  • By GlobeNewswire
  • Mar 4, 2020 7:00 AM EST
PRESS RELEASES

ContraFect Announces U.S. FDA Grants Breakthrough Therapy Designation To Exebacase For The Treatment Of Methicillin-Resistant Staphylococcus Aureus (MRSA) Bacteremia, Including Right-Sided Endocarditis

  • By GlobeNewswire
  • Feb 24, 2020 7:00 AM EST
PRESS RELEASES

ContraFect Announces One-for-Ten Reverse Stock Split

  • By GlobeNewswire
  • Feb 4, 2020 7:00 AM EST
PRESS RELEASES

ContraFect Appoints Jane E. Ambler, Ph.D. As Vice President Of Clinical Microbiology

  • By GlobeNewswire
  • Feb 3, 2020 7:00 AM EST
PRESS RELEASES

ContraFect Announces Oral Presentations At The 30th European Congress Of Clinical Microbiology And Infectious Diseases (ECCMID)

  • By GlobeNewswire
  • Jan 27, 2020 7:00 AM EST
5 Stocks Under $10 Setting Up to Trade Higher
OPINION

5 Stocks Under $10 Setting Up to Trade Higher

  • By Roberto Pedone
  • Nov 22, 2015 4:05 PM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.